Clinical trials recruiting for Metastatic Colorectal Adenocarcinoma
8
Recruiting trials
40
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Bevacizumab | 2 |
| Fluorouracil | 2 |
| Oxaliplatin | 2 |
| Balstilimab | 1 |
| Botensilimab | 1 |
| Cemiplimab | 1 |
| Cetuximab | 1 |
| EB-DUO-CAR-NK-CEA/GCC | 1 |
| Emavusertib | 1 |
| Fruquintinib | 1 |
| Fulvestrant | 1 |
| Leucovorin | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Michigan | 3 |
| New York | 3 |
| District of Columbia | 2 |
| Florida | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Maryland | 2 |
| Missouri | 2 |
| Oklahoma | 2 |
| Tennessee | 2 |
| Texas | 2 |
Top cities
Atlanta, Georgia 2Baltimore, Maryland 2Detroit, Michigan 2Flint, Michigan 2Gainesville, Florida 2Lansing, Michigan 2Los Angeles, California 2Nashville, Tennessee 2New York, New York 2Oklahoma City, Oklahoma 2
Self-screener
Recruiting trials
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
- Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
- Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
- Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
- Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
- Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Related conditions
Trials recruiting for Metastatic Colorectal Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Stage IV Colorectal Cancer AJCC v8 21Stage III Colorectal Cancer AJCC v8 10Triple-negative breast cancer 138Stage IVC Colorectal Cancer AJCC v8 7Stage IVB Colorectal Cancer AJCC v8 7Stage IVA Colorectal Cancer AJCC v8 7Stage IIIC Colorectal Cancer AJCC v8 3Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 3Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Colorectal Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.